Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan
NCT ID: NCT05609643
Last Updated: 2025-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2022-07-06
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Rinvoq is an approved drug for treating axSpA. Approximately 100 adult participants who are prescribed Rinvoq by their physician in accordance with local label will be enrolled in Japan.
Participants will receive Rinvoq as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 52 weeks.
There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets
NCT04340115
Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis
NCT02896127
Study of Adalimumab in Patients With Axial Spondyloarthritis
NCT00939003
Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
NCT00085644
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
NCT04436640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rinvoq
Participants will receive Rinvoq as prescribed by their physician according to local label.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant who is administered the first dose of Rinvoq for AS.
Exclusion Criteria
* Participant currently participating in another clinical study except non-interventional study.
* Participant for whom upadacitinib is contraindicated.
* Participants who are not registered within 14 days after initiation of Rinvoq treatment for AS.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kurotsuchi Orthopaedic Clinic /ID# 251076
Kasugashi, Aichi-ken, Japan
Japan Organization of Occupational Health and Safety Chubu Rosai Hospital /ID# 258201
Nagoya, Aichi-ken, Japan
Nagoya University Hospital /ID# 254435
Nagoya, Aichi-ken, Japan
Fujita Health University Hospital /ID# 258204
Toyoake, Aichi-ken, Japan
Tomita Clinic /ID# 251075
Kashiwa-shi, Chiba, Japan
Yamada Rheumatology Clinic /ID# 264182
Matsuyama, Ehime, Japan
Matsuyama Red Cross Hospital /ID# 261974
Matsuyama, Ehime, Japan
Noda Hospital /ID# 254429
Noda-shi, Fukui, Japan
Toyama Hospital /ID# 268281
Toyama, Fukui, Japan
Yagi Hospital /ID# 251078
Fukuoka, Fukuoka, Japan
Kunou Orthopedic Clinic /ID# 252168
Kitakyushu-shi, Fukuoka, Japan
Hospital of the University of Occupational and Environmental Health, Japan /ID# 252570
Kitakyushu-shi, Fukuoka, Japan
Inoue Hospital /ID# 261959
Takasaki-shi, Gunma, Japan
National Hospital Organization Asahikawa Medical Center /ID# 268282
Asahikawa, Hokkaido, Japan
Katayama Orthopedic Rheumatology Clinic /ID# 251071
Asahikawa-shi, Hokkaido, Japan
Sapporo Rheumatology and immunology clinic /ID# 256175
Sapporo, Hokkaido, Japan
Hokkaido University Hospital /ID# 258203
Sapporo, Hokkaido, Japan
Himeji Medical Center /ID# 255197
Himeji-shi, Hyōgo, Japan
Kobe Kaisei Hospital /ID# 251073
Kobe, Hyōgo, Japan
Hyogo Medical University Hospital /ID# 253200
Nishinomiya-shi, Hyōgo, Japan
Clinic Quest For Rheumatology & Well-being /ID# 268817
Mito, Ibaraki, Japan
Kanazawa University Hospital /ID# 252170
Kanazawa, Ishikawa-ken, Japan
Sanuki Municipal Hospital /ID# 251104
Sanuki-shi, Kagawa-ken, Japan
Kagoshima University Hospital /ID# 256997
Kagoshima, Kagoshima-ken, Japan
Toranomon Hospital Kajigaya /ID# 260158
Kawasaki-shi, Kanagawa, Japan
Takahashi Clinic /ID# 252924
Kawasaki-shi, Kanagawa, Japan
Kitasato University Hospital /ID# 254480
Sagamihara-shi, Kanagawa, Japan
Sakuragicho Yokohama Clinic /ID# 266671
Yokohama, Kanagawa, Japan
Yokohama City University Medical Center /ID# 258149
Yokohama, Kanagawa, Japan
Yokohama Minami Kyousai Hosp /ID# 252172
Yokohama, Kanagawa, Japan
Kyoto Okamoto Memorial Hospital /ID# 255153
Kuse District, Kyoto, Japan
Kyoto University Hospital /ID# 261970
Kyoto, Kyoto, Japan
Chiyoda Hospital /ID# 251077
Hyuga-shi, Miyazaki, Japan
National Hospital Organization Miyakonojo Medical Center /ID# 268280
Miyakonojō, Miyazaki, Japan
University of Miyazaki Hospital /ID# 266669
Miyazaki, Miyazaki, Japan
Yoshida Internal Medicine Clinic - Sakaki /ID# 268285
Sakaki, Nagano, Japan
Nagasaki Kita Hospital /ID# 266672
Nishisonogi-gun, Nagasaki, Japan
Sasebo Chuo Hospital /ID# 253202
Sasebo-shi, Nagasaki, Japan
Tenri Hospital /ID# 256996
Tenri-shi, Nara, Japan
Oribe Clinic of Rheumatism and Medicine /ID# 251079
Ōita, Oita Prefecture, Japan
National Hospital Organization Osaka Minami Medical Center /ID# 251072
Kawachinagano Shi, Osaka, Japan
Kinshukai Infusion Clinic /ID# 251070
Osaka, Osaka, Japan
Osaka City General Hospital /ID# 258202
Osaka, Osaka, Japan
Osaka Metropolitan University Hospital /ID# 254436
Osaka, Osaka, Japan
Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 252166
Osaka, Osaka, Japan
Osaka Medical and Pharmaceutical University Hospital /ID# 260159
Takatsuki-shi, Osaka, Japan
Koga Community Hospital /ID# 251074
Yaizu, Shizuoka, Japan
Anan Medical Center /ID# 268818
Anan-shi, Tokushima, Japan
Nishiogu Clinic /ID# 266670
Arakawa City, Tokyo, Japan
Juntendo University Hospital /ID# 251103
Bunkyo-ku, Tokyo, Japan
Tokyo Medical And Dental University Hospital /ID# 252569
Bunkyo-ku, Tokyo, Japan
Suzuki Clinic Orthopaedics River City /ID# 254482
Chuo-ku, Tokyo, Japan
National Hospital Organization Tokyo Medical Center /ID# 270441
Meguro City, Tokyo, Japan
Meiyo Immunology & Rheumatology Clinic /ID# 256176
Suginami -ku, Tokyo, Japan
500koku Orthopedic Clinic /ID# 268283
Nakaniikawa-gun, Toyama, Japan
Takaoka Rheumatic Orthopedic Clinic /ID# 252895
Takaoka-shi, Toyama, Japan
Toyama University Hospital /ID# 251682
Toyama, Toyama, Japan
Kasugai Clinic /ID# 253201
Fuefuki-shi, Yamanashi, Japan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Related info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P22-963
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.